Amalgamated Bank Ptc Therapeutics, Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 2,529 shares of PTCT stock, worth $99,212. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,529

Previous 2,529 -0.0%

Holding current value

$99,212

Previous $77,000 22.08%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$24.69 - $40.12 $3,086 - $5,015	125 Added 5.2%	2,529 $77,000
Q1 2024 Apr 23, 2024	SELL	$24.15 - $31.95 $171,175 - $226,461	-7,088 Reduced 74.67%	2,404 $70,000
Q4 2023 Feb 06, 2024	SELL	$18.07 - $29.37 $12,920 - $20,999	-715 Reduced 7.0%	9,492 $262,000
Q3 2023 Nov 08, 2023	BUY	$22.41 - $41.99 $4,257 - $7,978	190 Added 1.9%	10,207 $229,000
Q2 2023 Aug 11, 2023	BUY	$40.4 - $59.1 $27,350 - $40,010	677 Added 7.25%	10,017 $407,000
Q1 2023 May 02, 2023	SELL	$38.16 - $48.86 $60,674 - $77,687	-1,590 Reduced 14.55%	9,340 $452,000
Q4 2022 Feb 10, 2023	BUY	$33.53 - $54.79 $6,169 - $10,081	184 Added 1.71%	10,930 $417,000
Q3 2022 Nov 09, 2022	BUY	$41.85 - $53.85 $6,486 - $8,346	155 Added 1.46%	10,746 $539,000
Q2 2022 Aug 15, 2022	SELL	$25.6 - $45.23 $19,942 - $35,234	-779 Reduced 6.85%	10,591 $424,000
Q1 2022 Jun 30, 2022	SELL	$33.33 - $44.6 $28,463 - $38,088	-854 Reduced 6.99%	11,370 $424,000
Q4 2021 Feb 15, 2022	SELL	$35.36 - $41.86 $4,632 - $5,483	-131 Reduced 1.06%	12,224 $487,000
Q3 2021 Oct 29, 2021	SELL	$37.01 - $44.74 $28,164 - $34,047	-761 Reduced 5.8%	12,355 $460,000
Q2 2021 Aug 16, 2021	BUY	$37.95 - $49.37 $163,830 - $213,130	4,317 Added 49.06%	13,116 $554,000
Q1 2021 May 13, 2021	SELL	$46.8 - $68.92 $40,248 - $59,271	-860 Reduced 8.9%	8,799 $417,000
Q4 2020 Feb 12, 2021	BUY	$47.96 - $67.64 $2,398 - $3,382	50 Added 0.52%	9,659 $589,000
Q3 2020 Oct 30, 2020	SELL	$45.41 - $57.07 $12,623 - $15,865	-278 Reduced 2.81%	9,609 $449,000
Q2 2020 Aug 10, 2020	SELL	$42.56 - $54.98 $38,857 - $50,196	-913 Reduced 8.45%	9,887 $502,000
Q1 2020 May 13, 2020	SELL	$32.37 - $59.36 $10,941 - $20,063	-338 Reduced 3.03%	10,800 $482,000
Q4 2019 Feb 13, 2020	BUY	$32.22 - $50.07 $31,897 - $49,569	990 Added 9.76%	11,138 $535,000
Q3 2019 Nov 13, 2019	SELL	$33.82 - $48.17 $4,295 - $6,117	-127 Reduced 1.24%	10,148 $343,000
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $97,511 - $123,885	2,753 Added 36.6%	10,275 $462,000
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $25,000 - $35,146	890 Added 13.42%	7,522 $283,000
Q4 2018 Feb 15, 2019	BUY	$29.83 - $46.51 $197,832 - $308,454	6,632 New	6,632 $228,000
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $233,774 - $329,421	-6,896 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$25.7 - $47.88 $177,227 - $330,180	6,896 New	6,896 $233,000

Others Institutions Holding PTCT

# of Institutions

223

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Ptc Therapeutics, Inc. Transaction History